Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP653715.RA174H8JXDTJ_nlb6_ZhUB1fzjQo8LgMO8eaHhdCXh1KA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP653715.RA174H8JXDTJ_nlb6_ZhUB1fzjQo8LgMO8eaHhdCXh1KA130_assertion type Assertion NP653715.RA174H8JXDTJ_nlb6_ZhUB1fzjQo8LgMO8eaHhdCXh1KA130_head.
- NP653715.RA174H8JXDTJ_nlb6_ZhUB1fzjQo8LgMO8eaHhdCXh1KA130_assertion description "[EC is known for extensive epigenetic alterations, including overexpression of HDAC and DNMT enzymes, and the frequent epigenetic silencing of DNA repair genes such as MLH1, tumor suppressor genes PTEN, and progesterone receptor, which suggests a potentially high sensitivity of this type of cancer to HDAC inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653715.RA174H8JXDTJ_nlb6_ZhUB1fzjQo8LgMO8eaHhdCXh1KA130_provenance.
- NP653715.RA174H8JXDTJ_nlb6_ZhUB1fzjQo8LgMO8eaHhdCXh1KA130_assertion evidence source_evidence_literature NP653715.RA174H8JXDTJ_nlb6_ZhUB1fzjQo8LgMO8eaHhdCXh1KA130_provenance.
- NP653715.RA174H8JXDTJ_nlb6_ZhUB1fzjQo8LgMO8eaHhdCXh1KA130_assertion SIO_000772 23888962 NP653715.RA174H8JXDTJ_nlb6_ZhUB1fzjQo8LgMO8eaHhdCXh1KA130_provenance.
- NP653715.RA174H8JXDTJ_nlb6_ZhUB1fzjQo8LgMO8eaHhdCXh1KA130_assertion wasDerivedFrom befree-20150227 NP653715.RA174H8JXDTJ_nlb6_ZhUB1fzjQo8LgMO8eaHhdCXh1KA130_provenance.
- NP653715.RA174H8JXDTJ_nlb6_ZhUB1fzjQo8LgMO8eaHhdCXh1KA130_assertion wasGeneratedBy ECO_0000203 NP653715.RA174H8JXDTJ_nlb6_ZhUB1fzjQo8LgMO8eaHhdCXh1KA130_provenance.